High Note Wealth, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 126 filers reported holding ANI PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
High Note Wealth, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$336,864
+7.9%
5,8020.0%0.14%
+9.4%
Q2 2023$312,322
+35.5%
5,8020.0%0.13%
+33.7%
Q1 2023$230,455
-1.3%
5,8020.0%0.10%
-3.1%
Q4 2022$233,414
+5.6%
5,8020.0%0.10%
+11.4%
Q3 2022$221,000
-17.2%
5,8020.0%0.09%
-2.2%
Q4 2021$267,0005,8020.09%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
Sio Capital Management, LLC 40,000$1,124,0000.37%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders